| Biomarker ID | 1022 |
| PMID | 23201468 |
| Year | 2012 |
| Biomarker | TMPRSS2-ERG (v-ets erythroblastosis virus E26 oncogene homolog) >= 10 |
| Biomarker Basis | Expression Based |
| Biomolecule | mRNA |
| Source | Urine |
| Subjects | Humans |
| Regulation | NA |
| Odds Ratio/Hazard Ratio/Relative Risk | OR: 7.16 (95% CI, 2.54-20.15) |
| Effect on Pathways | NA |
| Experiment | Gleason Score <7 Vs Gleason score ≥ 7 |
| Type of Biomarker | Prognostic |
| Cohort | 443 men were screened after biopsies, out of which 247 did not have prostate cancer and 196 had. |
| Senstivity | NA |
| Specificity | NA |
| AUC | 0.840 (95% CI: 0.785–0.895) |
| Accuracy | NA |
| Level Of Significance | p<0.001 |
| Method Used | qRT-PCR |
| Clinical | No |
| Remarks | NA |
| Clinical Trial Number | NA |
| Degree Of Validity | Not validated on independent patient dataset |
| Technical Name | TMPRSS2-ERG |